Uritreat capsule 0.4 mg 10?s is an alpha 1-adrenergic blocking agent exhibiting selectivity for alpha 1 receptors in the human prostate {01}. Relaxation of smooth muscle in the bladder neck and prostate produced by alpha 1-adrenergic blockade results in improvement in urine flow rate and a reduction in symptoms of BPH
Side effects
Major & minor side effects for Uritreat capsule 0.4 mg 10?s

Fever with chills

Cough

Chest pain

Dizziness

Abnormal ejaculation rare

Headache

Runny Nose rare

Body pain

Decreased interest in sexual intercourse

Trouble sleeping

Uses of Uritreat capsule 0.4 mg 10?s
What is it prescribed for?

Benign prostatic hyperplasia
This medicine is used in the treatment of benign prostatic hyperplasia (prostate enlargement), a condition characterized by symptoms such as a weak urinary stream, difficulty urinating, loss of bladder control, etc.

Concerns

Frequently asked questions

Onset of action
The effect of this medicine can be observed in 4 to 8 hours after administration.

Duration of Effect
The amount of time for which this medicine remains active in the body is not clinically established.

Safe with Alchohol?
Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects. These side effects may include dizziness, headache, lightheadedness, etc. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you consume alcohol during treatment with this medicine.

Is it habit forming?
No habit forming tendency has been reported.

Usage in pregnancy?
This medicine is not recommended for pregnant women.

Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women.

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to tamsulosin or any other inactive ingredients present in the formulation.

Warnings

Warnings for special population

Pregnancy
This medicine is not recommended for pregnant women.

Breast-feeding
This medicine is not recommended for use in breastfeeding women.

General Warnings

Hypotension
The use of this medicine may cause vasodilation and low blood pressure (hypotension), especially orthostatic hypotension or other postural symptoms such as dizziness, lightheadedness, and palpitations. Close monitoring of blood pressure levels is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Glaucoma/Cataracts surgery
The use of this medicine increases the risk of intraoperative floppy iris syndrome. Patients undergoing cataract and glaucoma surgery should inform the surgeon about the current or previous use of this medicine so that the surgeon can make appropriate changes in the surgical technique to reduce the risk of intraoperative floppy iris syndrome.

Women and children
This medicine is not indicated for use in women and children.

Driving or operating machinery
The use of this medicine may cause symptoms such as blurred vision, dizziness, drowsiness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms.

Priapism
This medicine may rarely cause a very painful erection which may not subside (priapism). Seek immediate medical attention if this happens. If priapism is not treated, it may lead to impotence.

Dosage

Missed Dose
The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already the time for your next scheduled dose.

Overdose
Seek emergency medical treatment or contact the doctor in case of overdose.

Interactions
Interaction with Medicines

Diltiazem moderate

Erythromycin moderate

Ketoconazole severe

Itraconazole severe

Fluvoxamine moderate

Disease interactions

moderate
This medicine should be used with extreme caution in patients with liver function impairment due to the increased risk of worsening of the patient’s condition. Close monitoring of liver function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

moderate
This medicine should be used with extreme caution in patients with kidney function impairment due to the increased risk of worsening of the patient’s condition. Close monitoring of kidney function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

References

drugs.com –
Mechanism of action/Effect: [Internet].
Available from: https://www.drugs.com/mmx/tamsulosin-hydrochloride.html
[cited 30/6/2020].
2/6/2020

drugs.com –
Tamsulosin [Internet].
Available from: https://www.drugs.com/tamsulosin.html
[cited 30/6/2020].
2/6/2020